Meet Hannah: a 27-Year-Old with EDS, POTS, MCAS, and Blood Cancer Fundraising for Treatment in the USA

Hannah Evans, a 27-year-old woman from South Wales with several rare diseases, has reached her £37,500 fundraising goal that will support her trip to America to access an experimental and…

Continue Reading Meet Hannah: a 27-Year-Old with EDS, POTS, MCAS, and Blood Cancer Fundraising for Treatment in the USA
Kids Fighting Cancer and Sickle Cell Disease are Showing Everyone Their Strength Through Photos
fotografierende / Pixabay

Kids Fighting Cancer and Sickle Cell Disease are Showing Everyone Their Strength Through Photos

September was Childhood Cancer Awareness Month and Sickle Cell Awareness Month. To mark to occasion, the Aflac Cancer and Blood Disorders Center at the Children’s Healthcare of Atlanta released a…

Continue Reading Kids Fighting Cancer and Sickle Cell Disease are Showing Everyone Their Strength Through Photos
A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?
harshahars / Pixabay

A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?

According to a story from Boston Health News, The US Food and Drug Administration's Accelerated Approval program is being used to approve a steadily growing number of drugs in recent…

Continue Reading A Greater Number of Drugs Are Getting Cleared With the FDA’s Accelerated Approval. What Does This Mean?
Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure
SoFuego / Pixabay

Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure

According to a story from The Atlantic, the continual development of gene editing technologies like CRISPR have the potential to cure a substantial portion of rare diseases that are linked…

Continue Reading Rare Disease and Personal Identity: Why This Hemophilia Patient Isn’t Interested in a Cure

Desperate Housewives Actress Marcia Cross Says She Feels “Liberated” After Sharing Her Battle with Anal Cancer

Actress Marcia Cross, best known for her role as Bree Van de Kamp on Desperate Housewives, has shared that she is now healthy after battling anal cancer in a series…

Continue Reading Desperate Housewives Actress Marcia Cross Says She Feels “Liberated” After Sharing Her Battle with Anal Cancer

A Marketing Application for the Gene Therapy LentiGlobin as a Treatment for Beta-Thalassemia is Being Reviewed in Europe

According to a recent press release from Bluebird Bio, the European Medicines Agency has accepted and will review their marketing authorization application (MAA) for the investigational gene therapy LentiGlobin™ as…

Continue Reading A Marketing Application for the Gene Therapy LentiGlobin as a Treatment for Beta-Thalassemia is Being Reviewed in Europe
Plans for a Clinical Trial of Coversin in Patients With Thrombotic Microangiopathies Have Been Announced
mohamed_hassan / Pixabay

Plans for a Clinical Trial of Coversin in Patients With Thrombotic Microangiopathies Have Been Announced

A drug called Coversin is being investigated as a potential treatment for four orphan diseases: bullous pemphigoid (BP), atypical keratoconjunctivitis (AKC), thrombotic microangiopathies, and paroxysmal nocturnal hemoglobinuria (PNH). Recently, new…

Continue Reading Plans for a Clinical Trial of Coversin in Patients With Thrombotic Microangiopathies Have Been Announced
She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research
FotoshopTofs / Pixabay

She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research

According to a story from 9news.com.au, the first sign that Jemima Leydon had ovarian cancer was a stomachache. Her mother Megan assumed that it was just a stomach bug that…

Continue Reading She was Diagnosed with Ovarian Cancer at Age Five– Now She’s Advocating for More Research
Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease
jniittymaa0 / Pixabay

Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease

A new drug designed to treat MAC lung disease as part of a combination antibacterial drug regimen in adults with limited treatment options has been granted Accelerated Approval by the…

Continue Reading Arikayce® Granted Accelerated Approval by the FDA for the Treatment of MAC Lung Disease